Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.32
-0.5900-9.98%
Post-market: 5.29-0.0300-0.56%18:35 EDT
Volume:59.96M
Turnover:337.40M
Market Cap:2.31B
PE:-2.95
High:6.20
Open:6.04
Low:5.30
Close:5.91
52wk High:12.36
52wk Low:3.79
Shares:434.15M
Float Shares:415.00M
Volume Ratio:1.14
T/O Rate:14.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8042
EPS(LYR):-1.6909
ROE:-86.34%
ROA:-39.08%
PB:2.51
PE(LYR):-3.15

Loading ...

Oct 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 25, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $476,000.
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 26, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $484,000.
Aug 18, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Khan Najat proposes to sell 36,599 shares, with a total value of approximately $202,169.22.
Aug 11, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 617,875 Shares, with a total value of approximately $3.26 Million.
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson Christopher proposes to sell 138,574 Shares, with a total value of approximately $836,987.
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Gibson proposes to sell 20000 shares with a total value of approximately $127,400
Mar 05, 2025

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS' Officer Christopher Gibson proposes to sell 20,000 shares, with a total value of approximately $131,600.